A clinical case of COVID-19 infection in a young patient with a соmorbid pathology
- Authors: Vorobeva O.V.1
-
Affiliations:
- Chuvash State University
- Issue: Vol 13, No 3 (2022)
- Pages: 114-120
- Section: Case reports
- URL: https://journals.rcsi.science/clinpractice/article/view/90909
- DOI: https://doi.org/10.17816/clinpract90909
- ID: 90909
Cite item
Full Text
Abstract
Background: The COVID-19 pandemic has caused a rapid increase in the number of cases and high mortality worldwide. Here we report a clinical case of severe COVID-19 with the development of lethal complications in a young patient with an unfavorable comorbid background. Description of the case: Patient R., a 36-year-old male, was admitted to the infectious diseases department with the complaints of frequent unproductive cough, pyretic body temperature, headache. Computed tomography of the chest revealed bilateral polysegmental pneumonia with the damage of up to 65% of the lung tissue. PCR for SARS-CoV-2 mRNA was positive. The medical history mentioned arterial hypertension for five years, obesity (BMI 41.5). The disease lasted for about 7 days, the patient took antipyretic, antibacterial medication without noticeable improvement. Despite the ongoing therapy for two days, the signs of pulmonary heart failure increased, culminating in the cardiac arrest, unsuccessful resuscitation and biological death of the patient. A sectional study revealed signs of pronounced edema in the lungs with a hemorrhagic component, hemolyzed erythrocytes were found in the lumen of the alveoli. In the heart, a histological examination revealed unevenly hypertrophied cardiomyocytes with areas of fragmentation. In the epithelium of the renal tubules, signs of karyorrhexis were found, and multiple areas of erythrocyte infiltration were found in the stroma. Conclusion: The clinical case demonstrates a rapid fulminant course of COVID-19 in a young patient with arterial hypertension and obesity, who developed viral-bacterial pneumonia, which led to the development of pulmonary heart failure, pulmonary edema, and necronephrosis.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Olga V. Vorobeva
Chuvash State University
Author for correspondence.
Email: olavorobeva@mail.ru
ORCID iD: 0000-0003-3259-3691
SPIN-code: 5084-1379
MD, PhD
Russian Federation, 15, Moskovskii, Cheboksary, 428015References
- World Health Organization. Coronavirus disease 2019 (COVID-19) situation report 48. Available from: https://www.who.int/docs/defaultsource/coronaviruse/situationreports/20200308sitrep48covid19.pdf?sfvrsn=16f7ccef_4. Accessed: March 9, 2020.
- Klausberger M, Leneva IA, Egorov A, Strobl F. Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections. Vaccine. 2020;38(4):859–867. doi: 10.1016/j.vaccine.2019.10.083
- Ostroverkhova DS, Kuzmich NN, Kadochnikov VV. Elucidating binding sites and affinities of erα agonists and antagonists to human alpha-fetoprotein by in silico modeling and point mutagenesis. Int J Mol Sci. 2020;21(3):893–897. doi: 10.3390/ijms21030893
- Thomson А, Totaro R, Cooper W. Fulminant Delta COVID-19 myocarditis: a case report of fatal primary cardiac dysfunction. Eur Heart J Case Rep. 2022;6(4):ytac142. doi: 10.1093/ehjcr/ytac142
- Milla-Godoy GC, Park R, Jiang W. Fulminant COVID-19- associated myocarditis in an otherwise healthy female. Cureus. 2021;13(1):e12736. doi: 10.7759/cureus.12736
- Liu J, Deswal A, Khalid U. COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol. 2021;36(2):234–240. doi: 10.1097/HCO.0000000000000832
- Guerra MA, Lappot R, Urena AP. COVID-induced fulminant myocarditis. Cureus. 2022;14(4):e23894. doi: 10.7759/cureus.23894
- Забозлаев Ф.Г., Кравченко Э.В., Галлямова А.Р., Летуновский Н.Н. Патологическая анатомия легких при новой коронавирусной инфекции (COVID-19). Предварительный анализ аутопсийных исследований // Клиническая практика. 2020. Т. 11, № 2. C. 21–37. [Zabozlaev FG, Kravchenko EV, Gallyamova AR, Letunovsky NN. Pathological anatomy of the lungs in new coronavirus infection (COVID-19). Preliminary analysis of autopsy studies. Journal of Clinical Practice. 2020;11(2):21–37. (In Russ).] doi: 10.17816/clinpract34849
- Воробьева О.В., Ласточкин А.В. Изменения в головном мозге, легких и сердце при COVID-19 на фоне цереброваскулярной патологии // Профилактическая медицина. 2020. Т. 23, № 7. C. 43–46. [Vorobeva OV, Lastochkin AV. Changes in the brain, lungs and heart with COVID-19 against the background of cerebrovascular pathology. Prevent Med. 2020;23(7):43–46. (In Russ).]
- Воробьева О.В., Ласточкин А.В. Острый инфаркт миокарда и коронавирусная инфекция (COVID-19) // Инфекционные болезни: новости, мнения, обучение. 2021. Т. 10, № 1. C. 93–97. [Vorobeva OV, Lastochkin AV. Аcute myocardial infarction and coronavirus infection (COVID-19). Infectious Diseases News Opinions Education. 2021;10(1):93–97. (In Russ).] doi: 10.33029/2305-3496-2021-10-1-93-97